18128-Prostate Cancer-NA-1517

Prostate Cancer

CYCLONE 2: A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Address

5236 W University Dr, Suite 1000
McKinney, TX 75071
P: (972) 542-8609

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.